{"product_id":"memorial-sloan-kettering-cancer-center-msk-cardio-oncology-symposium-2024","title":"Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eMemorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eInclude: 60 videos + 43 pdfs, size: 22.3 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists, hematologists\/oncologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSample video: \u003cspan style=\"color: #0000ff;\"\u003e\u003ca href=\"https:\/\/medicalamboss.com\/contact-us\/\" style=\"color: #0000ff;\"\u003econtact me\u003c\/a\u003e \u003c\/span\u003efor sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThursday, May 2, 2024, 8:00 AM – Friday, May 3, 2024, 6:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eSpecialties\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Bone Marrow Transplant, Cardiology, Cellular Therapeutics, Critical Care, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Internal Medicine, Leukemia, Lymphoma, Radiation Oncology, Solid Tumor Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThe advances in cancer therapeutics has significantly improved cancer survival. With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate \u003cstrong\u003e2-5 times higher mortality risk due to cardiovascular diseas\u003c\/strong\u003ee than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns about the cardiovascular challenges faced by patients with cancer, the field of Cardio-Oncology has evolved, consisting of experts in both cancer and cardiovascular medicine working to \u003cstrong\u003eimprove the detection, monitoring, and treatment of cardiovascular disease at each stage of the cancer care continuum\u003c\/strong\u003e. The field is rapidly growing to meet the urgent need to improve the cardiovascular health of patients with cancer.\u003cbr\u003e\u003cbr\u003eJoin us in person in New York City for this \u003cstrong\u003estate-of-the-art, comprehensive, case-based curriculum\u003c\/strong\u003e addressing critical topics relevant to the cardiovascular health of patients with cancer and cancer survivors. Together, an interdisciplinary group, consisting of \u003cstrong\u003ecardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world\u003c\/strong\u003e, will present the latest research and contemporary practice strategies in the prevention, early diagnosis, and management of cardiovascular disease in cancer patients and cancer survivors. The symposium will include a series of talks highlighting cutting-edge and trending subjects in the rapidly evolving field of Cardio-Oncology, ensuring that participants gain insights into the most recent advancements shaping the future of cardiovascular care for cancer patients.\u003cbr\u003e\u003cbr\u003eThis symposium will offer a forum for \u003cstrong\u003enetworking and professional collaboration\u003c\/strong\u003e. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 2, 2024, following the symposium, to provide an opportunity for the Cardio-Oncology community to interact and get to know each other. \u003cstrong\u003ePlease RSVP for the networking reception during registration.\u003c\/strong\u003e We hope to see you there!\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis symposium is intended for cardiologists, internists, hematologists\/oncologists, advanced practice providers, nurses, housestaff and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this symposium, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe contemporary anti-cancer treatments (such as anthracyclines, targeted therapy, immunotherapy, cellular therapy, radiation), outlining their roles in cancer therapy, mechanisms of action, cardiotoxicity profiles, and their impact on the cardiovascular system\u003c\/li\u003e\n\u003cli\u003eDetermine the strategies for monitoring and managing cardiotoxicity, identifying the evidence and the knowledge gaps\u003c\/li\u003e\n\u003cli\u003eExplain the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy\u003c\/li\u003e\n\u003cli\u003eDemonstrate the principles of the permissive cardiotoxicity strategy and how it applies in specific treatment scenarios\u003c\/li\u003e\n\u003cli\u003eSummarize the appropriate use of imaging modalities in contemporary Cardio-Oncology, from guidelines to best practices\u003c\/li\u003e\n\u003cli\u003eState the late cardiovascular sequelae of cancer treatment and the best approach to managing the cardiovascular health of adult survivors of childhood cancer\u003c\/li\u003e\n\u003cli\u003eIllustrate the challenges of managing acute cardiovascular disease in patients during cancer treatment\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..mp4\u003c\/li\u003e\n\u003cli\u003e2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..pdf\u003c\/li\u003e\n\u003cli\u003e5FU Induced Chest Pain- Diagnostic and Management Algorithm.mp4\u003c\/li\u003e\n\u003cli\u003e5FU Induced Chest Pain- Diagnostic and Management Algorithm.pdf\u003c\/li\u003e\n\u003cli\u003eA Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.mp4\u003c\/li\u003e\n\u003cli\u003eA Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.pdf\u003c\/li\u003e\n\u003cli\u003eAmyloidosis and Multiple Myeloma- Contemporary Diagnosis and New Advances in Treatment Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.mp4\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.pdf\u003c\/li\u003e\n\u003cli\u003eBest Practices in the Management of Cardiovascular Disease in Patients with Cancer Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eBreast Cancer- Best Practice Strategies to Optimize Outcomes Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.pdf\u003c\/li\u003e\n\u003cli\u003eCancer Survivorship and Prevention Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..mp4\u003c\/li\u003e\n\u003cli\u003eCancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..pdf\u003c\/li\u003e\n\u003cli\u003eCancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.pdf\u003c\/li\u003e\n\u003cli\u003eCancer-Associated Stroke- Etiology, Detection and Management.mp4\u003c\/li\u003e\n\u003cli\u003eCancer-Associated Stroke- Etiology, Detection and Management.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.pdf\u003c\/li\u003e\n\u003cli\u003eCardio-Oncology- Moving the Field Forward Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCardioOnc2024_Brochure.pdf\u003c\/li\u003e\n\u003cli\u003eCardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.mp4\u003c\/li\u003e\n\u003cli\u003eCardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular Considerations in Hematologic Malignancies Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular Considerations of TKI Therapy in Chronic Leukemias.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular Considerations of TKI Therapy in Chronic Leukemias.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.mp4\u003c\/li\u003e\n\u003cli\u003eCardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.pdf\u003c\/li\u003e\n\u003cli\u003eCART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.mp4\u003c\/li\u003e\n\u003cli\u003eCART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.pdf\u003c\/li\u003e\n\u003cli\u003eCASE PRESENTATION- ICI Myocarditis Cases from Mild to Deadly.mp4\u003c\/li\u003e\n\u003cli\u003eCommon Risk Factors Between Cancer and Cardiovascular Disease.mp4\u003c\/li\u003e\n\u003cli\u003eCommon Risk Factors Between Cancer and Cardiovascular Disease.pdf\u003c\/li\u003e\n\u003cli\u003eContemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.mp4\u003c\/li\u003e\n\u003cli\u003eContemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.pdf\u003c\/li\u003e\n\u003cli\u003eContemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..mp4\u003c\/li\u003e\n\u003cli\u003eContemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..pdf\u003c\/li\u003e\n\u003cli\u003eCoronary Artery Disease in Cardio-Oncology Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eDeveloping a Cancer Survivorship Health Care Model.mp4\u003c\/li\u003e\n\u003cli\u003eElectrophysiology in Cardio-Oncology Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eFundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.mp4\u003c\/li\u003e\n\u003cli\u003eFundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.pdf\u003c\/li\u003e\n\u003cli\u003eHow I Use Strain and Biomarkers in My Practice.mp4\u003c\/li\u003e\n\u003cli\u003eHow I Use Strain and Biomarkers in My Practice.pdf\u003c\/li\u003e\n\u003cli\u003eHow to Manage Patients with Cardiac Implantable Devices During Radiation MRI.mp4\u003c\/li\u003e\n\u003cli\u003eHow to Manage Patients with Cardiac Implantable Devices During Radiation MRI.pdf\u003c\/li\u003e\n\u003cli\u003eHow to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.mp4\u003c\/li\u003e\n\u003cli\u003eHow to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.pdf\u003c\/li\u003e\n\u003cli\u003eIC-OS- Opportunities for Collaboration, Research, and Education.mp4\u003c\/li\u003e\n\u003cli\u003eIC-OS- Opportunities for Collaboration, Research, and Education.pdf\u003c\/li\u003e\n\u003cli\u003eImmunotherapy- Evolving Landscape in Diagnosing and Managing Immune Related Cardiotoxicity Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eImplications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.mp4\u003c\/li\u003e\n\u003cli\u003eImplications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.pdf\u003c\/li\u003e\n\u003cli\u003eLate Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.mp4\u003c\/li\u003e\n\u003cli\u003eLate Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.pdf\u003c\/li\u003e\n\u003cli\u003eLung Cancer- Advances in Treatment and Their Impact on Cardiovascular Health.mp4\u003c\/li\u003e\n\u003cli\u003eManaging Patients with TTR Amyloidosis- Progress and Challenges.mp4\u003c\/li\u003e\n\u003cli\u003eManaging Patients with TTR Amyloidosis- Progress and Challenges.pdf\u003c\/li\u003e\n\u003cli\u003eMetabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..mp4\u003c\/li\u003e\n\u003cli\u003eMetabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..pdf\u003c\/li\u003e\n\u003cli\u003eMR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.mp4\u003c\/li\u003e\n\u003cli\u003eMR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.pdf\u003c\/li\u003e\n\u003cli\u003eMultimodality Imaging – Which Test, When, and Why..mp4\u003c\/li\u003e\n\u003cli\u003eMultimodality Imaging – Which Test, When, and Why..pdf\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.mp4\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.pdf\u003c\/li\u003e\n\u003cli\u003eNavigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.mp4\u003c\/li\u003e\n\u003cli\u003eNavigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.pdf\u003c\/li\u003e\n\u003cli\u003eOptimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eOptimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..mp4\u003c\/li\u003e\n\u003cli\u003ePharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..pdf\u003c\/li\u003e\n\u003cli\u003ePrescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..mp4\u003c\/li\u003e\n\u003cli\u003ePrescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..pdf\u003c\/li\u003e\n\u003cli\u003ePrevention in Cardio-Oncology Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eProstate Cancer and Cardiovascular Disease Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eRacial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.mp4\u003c\/li\u003e\n\u003cli\u003eRacial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.pdf\u003c\/li\u003e\n\u003cli\u003eRadiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.mp4\u003c\/li\u003e\n\u003cli\u003eRadiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.pdf\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy and the Heart Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.mp4\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.pdf\u003c\/li\u003e\n\u003cli\u003eRole of Imaging Markers and Biomarkers in Cardio-Oncology- Strategies for Early Detection of Cardiotoxicity. Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eStriking the Balancing- Navigating Permissive Cardiotoxicity in Cancer Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eThe Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.mp4\u003c\/li\u003e\n\u003cli\u003eThe Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.pdf\u003c\/li\u003e\n\u003cli\u003eThrombosis and Hemostasis in Cancer Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eUnderstanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why..pdf\u003c\/li\u003e\n\u003cli\u003eUnderstanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why.mp4\u003c\/li\u003e\n\u003cli\u003eUpdates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.mp4\u003c\/li\u003e\n\u003cli\u003eUpdates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.pdf\u003c\/li\u003e\n\u003cli\u003eVenous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eVenous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954409312354,"sku":"MED-AMB02942","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Memorial-Sloan-Kettering-Cancer-Center-MSK-Cardio-Oncology-Symposium-2024-1.jpg?v=1779375769","url":"https:\/\/meducourse.com\/products\/memorial-sloan-kettering-cancer-center-msk-cardio-oncology-symposium-2024","provider":"Meducourse","version":"1.0","type":"link"}